Hildegund C. J. Ertl

Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA.

Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD.

AudioAudit, Inc. provides broadcast performance management and tracking solutions. It provides a web-based platform that automates the tracking process of advertising campaigns suitable for ad agencies, media buyers, and broadcasters. The company was founded by Burton L. Greenberg and Paul Hummel in 1994 and is headquartered in Paramus, NJ.

Syantra, Inc. engages in the development of cancer detection and treatment technology. It offers Syantra DX - Breast Cancer, a blood-based cancer detection assay that utilizes a novel suite of biomarkers and proprietary artificial intelligence-generated algorithms to provide a positive or negative result. The company was founded by Kristina Rinker and Kenneth Fuh and is headquartered in Calgary, Canada.

Axxia Pharmaceuticals LLC commercializes implantable, polymer-based drug delivery technology. It allows surgeons to remove and replace the implant at the end of its therapeutic life. The company is headquartered in Bel Air, MD.

Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile.

SIRPant Immunotherapeutics, Inc. is a clinical-stage immuno-oncology company based in Hummelstown, PA. The company specializes in developing next-generation macrophage-based immunotherapies for the treatment of hematological malignancies and solid tumors. The cell therapy technology employed by SIRPant is based on the reduction of SIRP? expression combined with activation of the patient's own macrophages. This population of SIRP?low activated macrophages is designed to attack the tumor following injection by activating the patient's immune system to produce broad-spectrum anti-tumor activity that utilizes patient T-cells and antibodies targeting cancer neoantigens. The company was founded by Richard F. Fitzgerald, and the CEO is Robert J. Towarnicki.

RxMP Therapeutics, Inc. develops and designs novel hemostatic agents to arrest or prevent excessive bleeding. The company is headquartered in Miami, FL.

Genomic Expression, Inc. is an American company that specializes in RNA analysis to detect diseases, monitor health, and design next-generation cures. The company offers COVID19 PCR testing as well as cancer testing. The company was founded by Gitte L. Pedersen and Morten Lorentz Pedersen, with Gitte L. Pedersen serving as the CEO since incorporation.

Keiretsu Capital LLC (Keiretsu) is a Venture Capital firm, a subsidiary of Keiretsu Forum LLC founded in 2013 by Matthew le Merle and Randy Williams. The firm headquartered in Seattle, Washington.

Operative Experience, Inc. develops and markets medical simulators. Its products include Labor and delivery simulators, surgery simulators, and tactical casualty care simulators. The company was founded by Robert F. Buckman, Jr. and is headquartered in North East, MD,

Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay.

The Children's Hospital of Philadelphia provides health care services. It specializes in pediatrics, research, fetal surgery, pediatric oncology, pediatric cardiology and cardiothoracic surgery, thoracic insufficiency syndrome, and pediatric airway disorders and transplants. The company was founded by Francis West Lewis in 1855 and is headquartered in Philadelphia, PA.

Sagemedic Corp. specializes in precision medicine for cancer patients. The American company's approach is designed to identify the most effective treatment options, overcoming the limitations of genomic testing. Sagemedic was founded by Christian Apfel and Brigitte Apfel, with Christian Apfel serving as CEO since incorporation.

Mid-Atlantic Diamond Ventures operates as an alternative investment manager. The company was founded in 2003 and is headquartered in Philadelphia, PA.

Mid Atlantic Bio Angels (MABA) is an venture capital firm founded in 2012 by Yaniv Sneor, Bernard Rudnick and Stephen Goodman. It is headquartered in New York, New York.

Midway Pharmaceuticals, Inc. develops non-antibiotic therapies. It capitalizes on the finding the molecular weight polymers, taken orally but not systemically absorbed, can inhibit the pathogenic behavior of bacteria in the GI tract, enhance gut barrier function and promote gastrointestinal healing. The company was founded by John Alverdy, Eugene Chang and Elaine Petrof in 2005 and is headquartered in Spring House, PA.

Ocean Biomedical, Inc. is a biopharmaceutical company. It engages in the business of discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. The company was founded by Chirinjeev Kathuria, Jonathan Kurtis and Jack A. Elias on January 2, 20219 and is headquartered in Providence, RI.

Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA.

The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC.

Meridian Venture Partners LLC (MVP Capital Partners) is a private equity firm founded in 1985 by Robert E. Brown and Bob Brown. The firm is headquartered in Radnor, Pennsylvania.